Prebiologic Therapy Tuberculosis Screening Experience in a Pediatric Rheumatology Center: TST and IGRA Are Both Necessary

Pediatric Infectious Disease Journal

Volumn 36, Issue 4, 2017, Pages 440-441

  Marino, Achille ^a   Chiappini, Elena ^a   Cimaz, Rolando ^a,b   Simonini, Gabriele ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; TUMOR NECROSIS FACTOR INHIBITOR; GAMMA INTERFERON;

ADOLESCENT; ANTIBIOTIC THERAPY; BIOLOGICAL THERAPY; CHILD; FEMALE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; LETTER; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS TEST KIT; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS; MASS SCREENING; RHEUMATOLOGY;

CHILD; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MASS SCREENING; RHEUMATOLOGY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 85016201990     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000001466     Document Type: Letter

References (7)

1. Lowenthal P, Barry PM, Flood J. High discordance between pre-US and post-US entry tuberculosis test results among immigrant children: Is it time to adopt interferon gamma release assay for preentry tuberculosis screening? Pediatr Infect Dis J. 2016;35:231-236.
2. Tebruegge M, Clifford V, Curtis N. Interferongamma release assays should not replace tuberculin skin tests in screening programs for children. Pediatr Infect Dis J. 2016;35:929.
3. Tebruegge M, Dutta B, Donath S, et al. Mycobacteria-specific cytokine responses detect tuberculosis infection and distinguish latent from active tuberculosis. Am J Respir Crit Care Med. 2015;192:485-499.
4. Ringold S, Weiss PF, Beukelman T, et al.; American Collge of Rheumatology. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Rheum. 2013;65:2499-2512.
5. Chiappini E, Lo Vecchio A, Garazzino S, et al.; Italian Pediatric TB Study Group. Recommendations for the diagnosis of pediatric tuberculosis. Eur J Clin Microbiol Infect Dis. 2016;35:1-18.
6. Calzada-Hernández J, Anton-López J, Bou-Torrent R, et al.; Carmen García de Vicuña Muñoz de la Nava. Tuberculosis in pediatric patients treated with anti-TNFα drugs: a cohort study. Pediatr Rheumatol Online J. 2015;13:54.
7. Solovic I, Sester M, Gomez-Reino JJ, et al. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J. 2010;36:1185-1206.